Abstract
We have shown that doxorubicin entrapped in cardiolipin liposomes retain antitumour efficacy in mice but had diminished cardiac uptake and cardiotoxicity. Such liposomes are preferentially taken up by spleen. In a previous study we showed that a single dose of liposomal doxorubicin is not more toxic than free doxorubicin with regard to immunologic parameters including generation of cytotoxicity for histocompatibility alloantigens and mitogenic responsiveness. In the present study, we have explored clinically relevant multiple dosing at weekly intervals, 2, 3, or 4 times. Again, despite splenic localization of liposomal doxorubicin, the depressive effect on these immunological parameters is not greater than the effect of free drug, and, in addition, the damage is repaired earlier.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Rahman, A., Joher, A. & Neefe, J. Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes. Br J Cancer 54, 401–408 (1986). https://doi.org/10.1038/bjc.1986.190
Issue Date:
DOI: https://doi.org/10.1038/bjc.1986.190
This article is cited by
-
Evaluation of triblock copolymeric micelles of δ- valerolactone and poly (ethylene glycol) as a competent vector for doxorubicin delivery against cancer
Journal of Nanobiotechnology (2011)
-
Novel drug delivery system using thermoreversible gelation polymer for malignant glioma
Journal of Neuro-Oncology (2006)
-
Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes
Cancer Chemotherapy and Pharmacology (1990)